Labsim shining appearance at WHX labs 2026 to deepen strategic cooperation in southeast asian markets.

From July 8 to 10, 2026, WHX Labs 2026 was successfully held in Bangkok, the capital of Thailand. Labsim showcased its pathology printers as well as POCT immunochromatography analyzers and supporting reagents. The booth drew an endless stream of visitors, with numerous core products attracting industry merchants for on-site consultations and in-depth business negotiations.

Leveraging self-developed core technologies, Labsim’s exhibits became the highlight of the entire show. Its ultra-compact pathology printer series stood out most, fully demonstrating China’s cutting-edge technological prowess in the segmented pathology printer sector to pathology professionals worldwide.

Labsim’s POCT immunochromatography product portfolio delivers a full-suite POCT integrated solution of instruments and reagents to global clients. It covers more than 100 reagent items across major testing categories: Inflammation, Sex Hormones, Thyroid Hormones, Growth Hormones, Cardiac Markers, Kidney Function, Diabetes, Tumor Markers, Infectious Diseases, Gastric Health, Anaemia, Neurological Indicators, Rheumatism and Allergens. Supported by a diversified product matrix and all-scenario clinical diagnostic solutions, Labsim is opening broader access to ASEAN markets.

 

 

Continuous product updates

Backed by strong R&D capabilities and a commitment to independent innovation, Labsim has obtained more than 300 national patents. The company’s quality management system is ISO 13485 certified, and multiple core products are CE and FDA marked, fully meeting the latest EU MDR and IVDR requirements.

 

Having cultivated the Southeast Asian market for years, Labsim joined the industry gathering to jointly outline the future blueprint for medical and healthcare development. The company is accelerating the development of a cross-border, cross-sector collaborative innovation ecosystem. It will keep advancing independent innovation, deepen its global strategic layout, and jointly explore the boundless potential of medical science.